KR20190094951A - Compositions including eriobotrya japonica extracts - Google Patents
Compositions including eriobotrya japonica extracts Download PDFInfo
- Publication number
- KR20190094951A KR20190094951A KR1020180014672A KR20180014672A KR20190094951A KR 20190094951 A KR20190094951 A KR 20190094951A KR 1020180014672 A KR1020180014672 A KR 1020180014672A KR 20180014672 A KR20180014672 A KR 20180014672A KR 20190094951 A KR20190094951 A KR 20190094951A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- tree
- aging
- weight
- present
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 44
- 235000009008 Eriobotrya japonica Nutrition 0.000 title claims abstract description 13
- 239000000203 mixture Substances 0.000 title claims abstract description 13
- 244000061508 Eriobotrya japonica Species 0.000 title abstract 3
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 13
- 241001092070 Eriobotrya Species 0.000 claims description 10
- 240000008397 Ganoderma lucidum Species 0.000 claims description 5
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 5
- 241001116498 Taxus baccata Species 0.000 claims description 5
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 3
- 230000032683 aging Effects 0.000 abstract description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 19
- 201000010099 disease Diseases 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 11
- 241000580955 Sapindus mukorossi Species 0.000 abstract description 2
- 241000392544 Dendropanax morbifer Species 0.000 abstract 1
- 241000390476 Ganoderma lingzhi Species 0.000 abstract 1
- 241000931143 Gleditsia sinensis Species 0.000 abstract 1
- 241000319057 Kalopanax septemlobus Species 0.000 abstract 1
- 244000162450 Taxus cuspidata Species 0.000 abstract 1
- 235000009065 Taxus cuspidata Nutrition 0.000 abstract 1
- 244000305267 Quercus macrolepis Species 0.000 description 12
- 239000000126 substance Substances 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 229920003266 Leaf® Polymers 0.000 description 5
- 208000001145 Metabolic Syndrome Diseases 0.000 description 5
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 210000004209 hair Anatomy 0.000 description 5
- 229930182490 saponin Natural products 0.000 description 5
- 235000017709 saponins Nutrition 0.000 description 5
- 150000007949 saponins Chemical class 0.000 description 5
- 241000208340 Araliaceae Species 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- -1 EC 1. 15. 1.1) Proteins 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 229930012538 Paclitaxel Natural products 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- 206010003246 arthritis Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229960001592 paclitaxel Drugs 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 208000004296 neuralgia Diseases 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 101100477600 Homo sapiens SIRT3 gene Proteins 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 101150009937 SIRT3 gene Proteins 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 230000006353 environmental stress Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 235000003969 glutathione Nutrition 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 239000006049 herbal material Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000004770 neurodegeneration Effects 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 108700003752 Drosophila Indy Proteins 0.000 description 1
- 108700030942 Drosophila Sirt2 Proteins 0.000 description 1
- 108700043134 Drosophila mth Proteins 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 241000617527 Ennomos alniaria Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 101000654471 Mus musculus NAD-dependent protein deacetylase sirtuin-1 Proteins 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 241001116500 Taxus Species 0.000 description 1
- 241000255588 Tephritidae Species 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 208000016599 Uterine disease Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000021045 dietary change Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 229940066493 expectorants Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 208000005346 nocturnal enuresis Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000017497 prostate disease Diseases 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000011506 response to oxidative stress Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 101150017120 sod gene Proteins 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 108091035539 telomere Proteins 0.000 description 1
- 102000055501 telomere Human genes 0.000 description 1
- 210000003411 telomere Anatomy 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 비파나무 추출물을 포함하는 조성물에 관한 것으로서, 보다 상세하게는, 특정 질병 또는 노화와 관련이 있는 각종 나무 추출물 조성물을 개발하도록 한 비파나무 추출물을 포함하는 조성물에 관한 것이다. The present invention relates to a composition comprising a locust extract, and more particularly, to a composition comprising a locust extract for developing various tree extract compositions associated with a specific disease or aging.
통계청이 발표한 2005년 총인구 중에서 65세 이상 노령인구의 비율은 9.1%를 차지하고 있고, 14세 이하 유년인구의 비중은 점차 줄어들고 있으며, 65세 이상 인구의 비중은 지난 2000년에 7.2%를 기록하여 우리 사회는 이미 고령화 사회로 진입한 것으로 평가된다. 또한, 2003년 기준으로 우리나라 국민의 평균수명은 77.5세로 노령인구가 급격하게 증가되고 있는 추세이다. 한편, 통계청이 발표한 우리나라 1인당 GNI는 2004년 14,162달러였으며, 매년 10% 이상 증가하고 있어 삶의 질은 점차 나아지고 있다고 할 수 있다. 이러한 사회적 조건의 변화에 의해, 과거 주요한 사망원인인 전염성 질병에 의한 사망자 수는 급격하게 줄어들고 있는 반면에 암, 뇌혈관질환, 대사증후군에 의한 사망자 수는 꾸준히 증가하고 있다.Of the total population released in 2005 by the National Statistical Office, the proportion of the elderly aged 65 and over occupied 9.1%, and the proportion of young people aged 14 and under was gradually decreasing, and the proportion of the population aged 65 and over recorded 7.2% in 2000. It is estimated that our society has already entered an aging society. In addition, as of 2003, the average life span of Korean people is 77.5 years old, and the elderly population is rapidly increasing. Meanwhile, Korea's GNI per capita announced by the National Statistical Office was $ 14,162 in 2004, and it is increasing by more than 10% every year. Due to such changes in social conditions, the number of deaths from infectious diseases, which are the major causes of death, has been drastically decreasing, while the number of deaths from cancer, cerebrovascular diseases, and metabolic syndrome is steadily increasing.
특히, 평균수명이 증가하고 사회의 고령화가 진행되면서 노화에 관한 관심 및 노화와 관련된 질병 특히, 뇌신경 세포 손상과 관련된 퇴행성 신경질환 등에 대한 관심이 증대되고 있다. 또한, 산업화 및 식생활의 변화에 따라 대사증후군의 발병률 및 이에 따른 사망률이 증가되면서 당뇨 또는 비만 등의 대사증후군에 대한 관심이 증대되고 있다. 이와 함께, 노화의 원인 및 다양한 질병의 원인으로 생각되는 활성산소(free radical)에 대한 관심이 증대되면서 항산화효과를 갖는 물질에 대한 관심이 증대되고 있다. 노화와 관련하여 다양한 정의가 있으며, 세포 복제와 관련하여 사람의 정상 체세포가 가지는 한정된 복제 수명 즉, 한정된 세포분열 후에 더 이상 세포 분열을 할 수 없는, 결국 역행할 수 없는 성장의 멈춤 단계를 노화로 정의한다 (Tominaga et al., Mech. Ageing Dev. 123: 927936 (2002)). 노화는 신경퇴화 질환, 암 또는 당뇨병 등의 대사증후군 등의 질병과 관련이 있으며, 이러한 노화와 관련된 원인으로 유전학적 원인, DNA손상의 축적(Sedelnikova et al., Nat. CellBiol. 6: 168170 (2004)), 산화적 스트레스에 대한 반응(Campisi et al., Exp. Gerontol. 36: 607618 (2001)), 텔로미어의 손상(Harrington and Robinson, Oncogene 21: 592597 (2002))등이 알려져 있다. 생물체에는 개체의 노화와 수명에 영향을 미치는 진화적으로 보존된 유전자 경로가 존재하는 것으로 보고되어 있고, 몇몇 실험동물의 경우 개체의 수명을 결정할 수 있는 유전자, 예를 들어 초파리의 methuselah, Indy 또는 Sir2 등이 보고되어 있다.In particular, as life expectancy increases and the aging of society progresses, interest in aging and diseases related to aging, in particular, degenerative neurological diseases related to cranial nerve cell damage, are increasing. In addition, as the incidence and mortality of metabolic syndrome increases with industrialization and dietary changes, interest in metabolic syndrome such as diabetes or obesity is increasing. In addition, as interest in free radicals, which are thought to cause aging and various diseases, has increased, interest in substances having an antioxidant effect is increasing. There are various definitions related to aging, and with regard to cell replication, the limited life span of normal somatic cells in humans, that is, no longer able to divide after limited cell division, and eventually stop the stage of growth that cannot be reversed, can be attributed to aging. (Tominaga et al., Mech.Aging Dev. 123: 927936 (2002)). Aging is associated with diseases such as neurodegenerative disease, metabolic syndrome such as cancer or diabetes mellitus, and the causes related to aging are genetic causes and accumulation of DNA damage (Sedelnikova et al., Nat. Cell Biol. 6: 168170 (2004). ), Response to oxidative stress (Campisi et al., Exp. Gerontol. 36: 607618 (2001)), and telomeres damage (Harrington and Robinson, Oncogene 21: 592597 (2002)). Living organisms have been reported to have evolutionarily conserved genetic pathways that affect the aging and longevity of an individual, and in some experimental animals genes that can determine the longevity of an individual, such as Drosophila methuselah, Indy or Sir2. And the like have been reported.
한편, 대부분의 생물은 병균, 해충 또는 바이러스 등의 생물학적 스트레스 뿐만 아니라 지구 환경 악화에 따라 생기는 각종 환경 스트레스를 받으면 생명 유지에 필요한 필수 원소인 산소는 반응성이 높아 심각한 생리적 장애 등을 유발하는 활성산소종(reactive oxyzen species)으로 변하게 된다. 따라서 생체 내에는 이러한 활성산소종을 제거하는 시스템으로 슈퍼 옥사이드 디스뮤타제(superoxide dismutasse, SOD, EC 1. 15. 1. 1), 퍼옥시다제(perosidase, POD), 카탈라제(catalase, CAT) 등의 고분자 항산화 효소와 비타민 C, 비타민 E 또는 글루타치온(glutathion) 등의 항산화 물질 등이 많이 존재하게 된다.On the other hand, most living organisms are oxygen free radicals that cause severe physiological disorders due to high reactivity, because oxygen, an essential element necessary for life, is subjected to various environmental stresses caused by deterioration of the global environment as well as biological stress such as germs, pests or viruses. (reactive oxyzen species). Therefore, it is a system for removing such active oxygen species in the living body, such as superoxide dismutasse (SOD, EC 1. 15. 1.1), peroxidase (POD), catalase (CAT), etc. There are a lot of polymer antioxidant enzymes and antioxidants such as vitamin C, vitamin E or glutathione (glutathion).
이 중, 슈퍼옥사이드 디스뮤타제(SOD)는 거의 모든 생물에 존재하고, 활성산소종을 제거하는 생체 방어 기구에 중요한 역할을 하는 것으로 보고되어 있다.Among them, superoxide dismutase (SOD) is present in almost all organisms, and has been reported to play an important role in biological defense mechanisms that eliminate free radical species.
상기와 같은 대사증후군 및 퇴행성 신경질환 등의 질병을 예방 또는 개선하는 물질 특히, 사람 개체의 노화를 방지할 수 있는 즉, 수명을 연장할 수 있는 물질이나 체내에서 활성산소종을 제거하거나 활성산소종의 활성을 약화시키는 물질을 검색하는 방법을 수립하기는 어렵다.Substances that prevent or ameliorate diseases such as metabolic syndrome and neurodegenerative diseases, in particular, those that can prevent aging of human subjects, that is, extend the lifespan or remove free radicals from the body or reactive oxygen species It is difficult to establish a method of searching for a substance that weakens the activity of.
그러나, 최근에는 특정 질병 또는 노화와 관련이 있는 유전자의 발현을 조절할 수 있는 물질을 개발함으로써 상기 질병을 예방 또는 개선하는 물질 또는 노화방지 물질을 개발하는 방법이 제시되고 있다. 식물이 환경 스트레스에 반응하여 생산하는 레스베라트롤 등의 폴리페놀 물질이 Sir2의 활성을 촉진시킴으로써 효모의 복제 수명과 꼬마선충 또는 초파리 등의 수명을 증가시키고 사람 세포의 생존능력을 향상시키는 현상이 보고됨으로써 상기 방법의 타당성이 입증되었다.However, recently, a method of developing a substance or an anti-aging substance for preventing or ameliorating the disease by developing a substance capable of controlling the expression of a gene associated with a specific disease or aging has been proposed. Polyphenols, such as resveratrol produced by plants in response to environmental stress, promote the activity of Sir2, increasing the lifespan of yeast replication and the life of small nematodes or fruit flies and improving human cell viability. The validity of the method has been demonstrated.
상기와 같은 타당성이 입증됨에 따라, SIRT3 유전자 등과 같이 특정 질환 또는 사람 개체의 수명과 밀접한 상관관계가 있는 유전자를 대상으로 이들 유전자의 발현을 조절할 수 있는 물질을 부작용의 위험성이 최소화된 천연물로부터 개발하려는 요구가 증대되고 있다.As the above validity has been proved, a substance that can regulate the expression of these genes, such as the SIRT3 gene, which is closely correlated with the lifespan of a particular disease or human individual, is developed from natural products with minimal risk of side effects. The demand is increasing.
또한, 활성 지속 기간이 길지 않은 문제점을 해결하기 위하여, 체내에서 활성산소종을 제거할 수 있는 SOD의 발현을 조절할 수 있는 물질을 부작용의 위험성이 최소화된 천연물로부터 개발하려는 요구가 증대되고 있다.In addition, in order to solve the problem that the duration of activity is not long, there is an increasing demand to develop a substance capable of regulating the expression of SOD capable of removing reactive oxygen species from the body from natural products with minimal risk of side effects.
이러한 요구에 따라, SIRT3 유전자 및 SOD 유전자의 발현을 조절할 수 있는 천연식물 유래의 물질을 찾으려는 노력이 진행 중에 있다.In response to these demands, efforts are underway to find substances derived from natural plants that can regulate the expression of the SIRT3 gene and the SOD gene.
본 발명은 상기한 종래 기술의 요망에 부응하기 위하여 발명된 것으로서, 특정 질병 또는 노화와 관련이 있는 각종 나무 추출물 조성물을 개발하도록 한 비파나무 추출물을 포함하는 조성물을 제공하는데 있다.The present invention has been invented in order to meet the above-mentioned demands of the prior art, and to provide a composition comprising a loquat extract to develop various tree extract compositions associated with a specific disease or aging.
본 발명의 제1 실시예에 의한 비파나무 추출물을 포함하는 조성물은, 비파나무 추출물 32~37 중량%와, 엄나무 추출물 12~17 중량%와, 무환자나무 추출물 12~17 중량%와, 황칠나무 추출물 11~16 중량%와, 조각자나무 추출물 18~23 중량%와, 영지버섯 추출물 0.3~0.7중량%와, 주목나무열매 추출물 0.3~0.7 중량%로 이루어진 것을 특징으로 한다. The composition comprising the loquat extract according to the first embodiment of the present invention, 32-37% by weight of the loquat extract, 12-17% by weight of the oak extract, 12-17% by weight of the no-tree extract, Hwangchil-tree extract 11 to 16% by weight, 18-23% by weight of the extract of engraved tree, 0.3-0.7% by weight of Ganoderma lucidum extract, 0.3-0.7% by weight of yew fruit extract.
본 발명의 비파나무 추출물을 포함하는 조성물에 의하면, 특정 질병 또는 노화와 관련이 있는 각종 나무 추출물 조성물을 개발 복용하도록 함으로써 질병 및 노화를 예방하는 효과를 가지고 있다. According to the composition comprising the loquat extract of the present invention, it has the effect of preventing disease and aging by developing and taking various tree extract compositions associated with a specific disease or aging.
이하, 본 발명의 바람직한 실시예를 당해 분야의 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 설명하기로 한다. 본 발명을 설명함에 있어 관련된 공지의 기능 또는 공지의 구성에 대한 구체적인 설명이 본 발명의 요지를 불필요하게 흐릴 수 있다고 판단되는 경우에는 그 상세한 설명을 생략하기로 한다. Hereinafter, preferred embodiments of the present invention will be described to be easily implemented by those skilled in the art. In describing the present invention, when it is determined that a detailed description of a related known function or known configuration may unnecessarily obscure the subject matter of the present invention, the detailed description thereof will be omitted.
본 발명에서 사용한 용어는 단지 특정한 실시 예를 설명하기 위해 사용된 것으로, 본 발명을 한정하려는 의도가 아니다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다. 본 출원에서, "포함하다" 또는 "가지다" 등의 용어는 명세서상에 기재된 특징, 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것이 존재함을 지정하려는 것이지, 하나 또는 그 이상의 다른 특징들이나 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다.The terminology used herein is for the purpose of describing particular example embodiments only and is not intended to be limiting of the present invention. Singular expressions include plural expressions unless the context clearly indicates otherwise. In this application, the terms "comprise" or "have" are intended to indicate that there is a feature, number, step, operation, component, part, or combination thereof described in the specification, and one or more other features. It is to be understood that the present invention does not exclude the possibility of the presence or the addition of numbers, steps, operations, components, components, or a combination thereof.
다르게 정의되지 않는 한, 기술적이거나 과학적인 용어를 포함해서 여기서 사용되는 모든 용어들은 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미를 가지고 있다. 일반적으로 사용되는 사전에 정의되어 있는 것과 같은 용어들은 관련 기술의 문맥상 가지는 의미와 일치하는 의미를 가지는 것으로 해석되어야 하며, 본 출원에서 명백하게 정의하지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다.Unless defined otherwise, all terms used herein, including technical or scientific terms, have the same meaning as commonly understood by one of ordinary skill in the art. Terms such as those defined in the commonly used dictionaries should be construed as having meanings consistent with the meanings in the context of the related art, and are not construed in ideal or excessively formal meanings unless expressly defined in this application. Do not.
이하, 본 발명의 바람직한 실시예를 상세히 설명하기로 한다. 아울러 본 발명을 설명함에 있어서, 관련된 공지 구성 또는 기능에 대한 구체적인 설명이 본 발명의 요지를 흐릴 수 있다고 판단되는 경우에는 그 상세한 설명을 생략한다.Hereinafter, preferred embodiments of the present invention will be described in detail. In addition, in describing the present invention, when it is determined that the detailed description of the related known configuration or function may obscure the gist of the present invention, the detailed description thereof will be omitted.
[실시예]EXAMPLE
본 발명의 비파나무 추출물을 포함하는 조성물은, 비파나무 추출물 32~37 중량%와, 엄나무 추출물 12~17 중량%와, 무환자나무 추출물 12~17 중량%와, 황칠나무 추출물 11~16 중량%와, 조각자나무 추출물 18~23 중량%와, 영지버섯 추출물 0.3~0.7중량%와, 주목나무열매 추출물 0.3~0.7 중량%로 이루어진다. The composition comprising the loquat extract of the present invention, 32-37% by weight of the loquat extract, 12-17% by weight of the oak extract, 12-17% by weight of the no-tree extract, and 11-16% by weight of the Hilchi chinensis extract , Engraver tree extract 18-23% by weight, Ganoderma lucidum extract 0.3-0.7% by weight, and yew tree fruit extract 0.3-0.7% by weight.
상기 나무들의 추출물은 하기와 같은 공정을 거쳐 만들어진다. Extracts of the trees are made through the following process.
즉, 나무를 벌채하여 물로 깨끗이 씻은 후 통풍이 잘되는 그늘에서 5~7일 동안 건조시킨다. 5ℓ의 부피에 해당하는 건조된 나무를 두께 2~3㎝의 크기로 잘라 10ℓ의 지장수가 담긴 솥에 넣고 150~180℃로 42시간 ~ 45시간동안 끓인다. 상기와 같이 끓이면 나무 속의 영양분이 추출된다. 이 추출물을 여과하여 사용한다. That is, the trees are felled, washed thoroughly with water, and dried in a well-ventilated shade for 5-7 days. Cut the dried tree corresponding to the volume of 5ℓ into the size of 2-3cm thick and put it in the pot containing 10ℓ jijisu water and boil at 150 ~ 180 ℃ for 42 ~ 45 hours. Boiling as described above extracts the nutrients in the tree. This extract is used by filtration.
상기 비파나무는, 가지가 굵고 잎의 뒷면과 더불어 연한 황갈색 털이 빽빽이 난다. 어린가지에 갈색의 부드러운 털이 붙어 있다. 관상용, 식용, 약용으로 이용된다. 열매는 달콤하고 감미로우며 당분과 함께 비타민 A, B, C가 많이 들어 있다. 씨를 비파라 하며 행인(杏仁)의 대용 약재로 쓴다. 잎 뒷면의 털을 없앤 것을 비파 엽이라 하고 약용한다. 약으로 쓸 때는 탕으로 하거나 산제 또는 환제로 하여 사용한다. The loquat has thick branches and dense light tan hairs with the back of the leaves. Sprigs have brown soft hairs. It is used for ornamental, edible and medicinal purposes. The fruit is sweet and sweet and contains lots of vitamins A, B, and C with sugar. The seed is called bibi and used as a substitute medicine for almonds. Remove the hair on the back of the leaf is called loquat medicinal. When used as a medicine, use it as a bath, powder, or pill.
엄나무는 쌍떡잎식물로 산형화목 두릅나무과의 낙엽교목이다. 주로 한국, 일본, 만주, 중국에서 분포되며, 크기는 높이 25m 정도된다. 엄마누 또는 엄목이라고도 부르며 지방에 따라서는 개두릅나무라고도 부르며 추운 지방일수록 더 잘 자라는 식물이다. 엄나무는 보통 속껄집이나 뿌리를 이용하여 술을 담그거나 약재료로 자주 사용된다. 한방에서는 관절염에 특히 효과가 아주 좋다고 하여 한방 재료로 많이 애용된다The oak tree is a dicotyledonous plant and is a deciduous tree of the arboraceae family. It is mainly distributed in Korea, Japan, Manchuria, and China, and its size is about 25m in height. It is also called mother's silkworm or stiffwood, and depending on the region, it is also called kaleidolp. The colder the plant, the better it grows. The oak tree is usually used as a medicinal ingredient to soak liquor using the inner house or root. In oriental medicine, it is especially effective for arthritis, so it is widely used as an herbal material.
한방 재료로 많이 이용한다는 엄나무는 관절염 등에서 효과가 아주 좋다. 이외에, 강장, 해열 , 피로회복에 좋다. 엄나무의 줄기를 달여서 차로 만들어 먹으면 몸에 아주 좋은 건강음료가 된다. 이 엄나무로 만든 건강음료는 특히 강장, 해열 , 피로회복에 아주 좋다. 또한 엄나무의 근피와 수피는 한방에서는 거담제로도 쓰인다. The oak tree, which is widely used as an herbal material, is very effective in arthritis. In addition, it is good for tonic, fever and fatigue. The stem of the oak tree is made of tea and eaten to make it a very healthy drink. The health drink made of this moth is especially good for tonic, fever and fatigue. The bark and bark of the oak are also used as expectorants in Korean medicine.
엄나무의 껍질은 해동피라고 부르는 데, 이 해동피는 중추신경을 진정시켜 주는 효과가 있으므로 류머티즘성 괄절염에 아주 효과적이다. 관절염에 의한 신경, 근육의 통증을 완화해주기도 하고, 엄나무 껍질인 해동피는 주로 닭백숙 삼계탕에 넣어 먹는다. 또한 해동피는 한방에서도 신경통, 당뇨병, 신장병을 치료하는데 아주 좋다고 전해지고 있다.The bark of the oak tree is called thawing blood, which is very effective for rheumatoid spondylitis because it has a calming effect on the central nerve. It also relieves nerve and muscle pain caused by arthritis. Haedongpi, the bark of oak, is usually eaten in chicken baeksook samgyetang. Haedongpi is also said to be very good for treating neuralgia, diabetes and kidney disease in Korean medicine.
또한, 엄나무는 당수치를 효율적으로 낮추어주는 효능을 가지고 있어 당뇨병 환자들에게 아주 좋고, 특히 엄나무의 잎과 껍질을 달여서 꾸준히 먹으면 당뇨개선에 효과적이다.In addition, the oak tree has an effect of effectively lowering the sugar level is very good for diabetics, especially if the leaf and bark of the oak tree to continue eating it is effective in improving diabetes.
또한 엄나무에는 사포닌 성분이 있어서 기침 및 가래 증상을 앓고 계신 분들에게 아주 좋고, 엄나무 뿌리를 즙으로 만들어 꾸준히 복용하다보면 기침과 가래 증상에 특히 더 효과적이며, 또한 이 사포닌 성분은 면역력을 강화시켜주는 효과도 있다. In addition, the saponin ingredient in sapwood is very good for people with cough and sputum symptoms, and it is especially effective for cough and sputum symptoms by taking the root of juice from the roots of juice. There is also.
간이 좋지 않으신 분들이 자주 찾는 음식이 바로 엄나무인데, 이 엄나무에는 간의 해독작용을 도와주는 성분이 있어 간에 아주 좋다. 또한 부족한 기를 보충해주며, 소화기능 개선효과까지 가지고 있다. 간암, 간경화, 간암 환자들에게는 치료로도 엄나무가 자주 쓰인다고 한다. People who do not have good liver often finds food that is very good because it has ingredients that help the liver detoxify. It also replenishes lack of energy and has digestive effects. It is said that the oak tree is often used as a treatment for patients with liver cancer, cirrhosis and liver cancer.
엄나무는 예전부터 민간요법으로 피부에 대한 치료에 자주 쓰이곤 했는데, 엄나무는 피부병, 궤양, 상처 등 피부 관련 질환을 치료하는 효과가 있다. Om has long been used as a folk remedy for the treatment of skin, which has the effect of treating skin-related diseases such as skin diseases, ulcers and wounds.
상기 무환자나무(Sapindus mukorossi)는 무환자나무과의 열대 아시아 원산으로 열대지방에서는 상록수이지만 추운지방에서는 낙엽이 진다. 잔가지는 굵고 녹갈색이며 털이 없고 도드라진 껍질눈이 흩어져 난다. 겨울눈은 반구형이며 길이가 1㎜ 정도로 작고 4개의 눈비늘 조각에 싸여 있다. 높이가 15~25m까지 자라며 개화기는 6~7월이고 결실기는 9~11월이다. 우리나라 남쪽 지방에 자라며 나무껍질은 연한 황갈색이며 잎자국은 세모꼴로 삼각형~하트형이며 관다발 자국은 3개이다. 잎은 어긋나고 깃꼴겹잎이다. 작은 잎은 8~16개로 거의 마주나듯이 어긋나는 짝수 모양의 겹잎이며 긴 타원형이며 끝이 뾰족하고 가장자리가 밋밋하다. 암수한그루로 가지끝의 원추꽃차례에 자잘한 황록색 꽃이 모여 핀다. 수꽃은 8개의 수술이 있고, 암꽃은 1개의 암술이 있다. 둥근 열매는 지름이 20~30㎜이고, 황갈색으로 익으며 속에 들어 있는 검은색의 구슬같은 씨는 15~20㎜ 인데 불교에서 염주를 만드는 데 사용하며 목재를 태우면 좋은 향기가 난다고 하며, 무환자나무로 만든 목침이 좋다고 전해져 온다. Sapindus mukorossi is native to tropical Asia of the Amacaceae family, and it is an evergreen tree in the tropics but leaves in the cold regions. Twigs are thick, greenish brown, hairless, and crusty. Winter snow is hemispherical, 1mm long, wrapped in 4 pieces of snow scales. It grows up to 15 ~ 25m in height, blooms from June to July, and fruiting season is from September to November. It grows in the southern part of Korea, the bark is light yellowish brown, and the leaf traces are triangular, triangular to heart-shaped, and the tube bundle is three. The leaves are alternate and the pinnate leaves. The leaf is 8 ~ 16 small leaves with evenly-shaped even leafs alternately facing each other, long oval, pointed at the end, and the edge is flat. Male and female, small yellow-green flowers gather in conical at the end of branches. Male flowers have 8 stamens, and female flowers have 1 pistil. The round fruit is 20-30mm in diameter, ripened yellowish brown, and the black bead-like seed inside is 15-20mm. It is used to make beads in Buddhism, and it is said to have good fragrance when burning wood. It is said that the made needle is good.
무환자나무의 줄기의 속껍질과 열매껍질에는 많은 양의 사포닌 성분이 들어 있어서 거품이 잘 일기 때문에 옛날에는 비누 대용으로 빨래하는 데 쓰이고 열매껍질은 머리를 감는데 사용되어 왔다. 열매의 표면이 윤기가 나면서 약간 쭈굴 쭈굴하게 생겼는데 흔들어 보면 사각 사각 검정색의 씨가 구르는 소리가 난다. The inner and fruit bark of the stems of the patient-free tree contains a large amount of saponin, which foams well, so in the past it was used to wash soap and fruit bark was used to wash the hair. The surface of the fruit is shiny and slightly crunchy, but when you shake it, you will hear a crunchy black seed.
예로부터 비누 성분인 사포닌이 많아서 빨래할 때 비누 대용으로 사용되어온 열매의 과육은 세수과(洗手果) 즉 손을 씻을 때 쓰는 과일이라는 뜻을 전달하고 있다.Since ancient times, saponins, soap ingredients, have been used as soap substitutes when washing fruit pulp (과 手 果), which means the fruit used to wash hands.
상기한 바와 같은 무환자나무는 지혈하고, 구워 먹으면 기생충을 구제하며, 노폐물을 제거한다. 달여서 고약을 만들어 쓰면 풍사(風邪)를 몰아내고 부기를 가라앉히며 독을 배출시킨다.As described above, the patient-bleeding tree hemostasis, bake and exterminate parasites, remove waste products. Decoction by making a decoction to drive out the wind sand (風邪), to reduce the swelling and discharge the poison.
무환자나무를 태워서 그 재를 가루내어 인후에 불어 넣으면 목소리가 쉰 증상이 치료된다고 한다. Burning the patient's tree, pulverizing the ash and blowing it into the throat cures the symptoms of hoarseness.
무환자나무의 어린 가지와 잎인 무환자엽(無患子葉)은 내복함과 동시에 바르면 뱀에 물린 상처를 치료할 수 있다고 하며, 백일해의 치료에 효과적이다. The leaves and young leaves of the patient-free tree, which have no internal use, can be used to cure snake bites when applied to the skin at the same time.
무환자나무의 뿌리인 무환수강은 감기로 인한 발열, 기침, 토혈, 백탁, 백대하를 치료한다고 한다. The roots of the tree, which is the root of the tree, is said to treat colds caused by fever, cough, hemorrhage, cloudiness, and white crabs.
전라도, 경상남도, 제주도 등지와 일본 오키나와, 혼슈남부에 분포하는 높이가 꽤 큰, 15m인 황칠나무는 어린 가지에는 털이 없는 녹색이다. 덜 자란 황칠나무 경우에는 세 개에서 다섯 개로 갈라져 있고 톱니가 있는데, 이 나무는 목공예품으로 유명한데, 표면을 만들거나, 색을 칠할 때 사용된다. 수액을 목공예에 사용하기도 한다. 또한 산삼이나 인삼에 많다는 사포닌이 많아 약재로도 쓰이는데, 이렇게 약재 및 목공예품 외에도 다양한 황칠나무의 효능을 하기에서 설명한다. Hwangchil-tree, which is 15m in height and distributed in Jeolla-do, Gyeongsangnam-do, Jeju-do, and Okinawa, Japan and south of Honshu, is green without hairs. Less-grown hwangchil trees are divided into three to five and have sawtooth, which is famous for carpentry, which is used for making surfaces and for coloring. Sap is also used in woodworking. In addition, there are a lot of saponins in wild ginseng or ginseng, which is also used as a medicinal herb.
우리들의 신경은 스트레스로 인해 과열되어 있다. 또한 직장이나 학업업무, 집안일 외에도 내 생활패턴 자체가 불규칙적이어서 이에 의한 정서불안, 불면증, 우울증도 많은데, 황칠나무로 만들어진 차를 자주 마실 경우에 신경이 안정된다. Our nerves are overheated by stress. In addition to my work, academic work, and household work, my life pattern itself is irregular, so there are many feelings of anxiety, insomnia, and depression.
여성 경우에는 생리가 제 때에 나오지 않는 것 또한 상당히 신경이 쓰이는 일로서, 여성의 자궁질환이나 생리불순, 남성의 경우에는 전립선 염증, 신경선 전립선질환, 전립선비대증을 개선해주는데 황칠나무가 도움이 된다고 합니다. 이 외에도 배뇨기능 질환에 해당하는 혈뇨, 야뇨증, 요실금 치료에 도움이 되고 방광이 건강해질 수 있도록 돕는다. 또 전립선을 수술하신 분들이 회복하는 데에도 도움이 된다고 한다. In women, menstruation does not come out on time, which is quite annoying, and it is said that Hwangchil Tree helps to improve uterine disease or menstrual disorders in women, prostate inflammation, neural prostate disease, and prostatic hyperplasia in men. . In addition, it helps to cure hematuria, nocturnal enuresis, and urinary incontinence, which is a urination function disease, and helps the bladder to be healthy. It also helps people who have had prostate surgery recover.
이 황칠나무에는 사포닌이라고 인삼 , 산삼에 들어있는 성분이 많이 있는 바, 이 성분은 항암 효과가 있어서 임상실험에도 많이 사용된다. This hwangchil wood contains a lot of ingredients in saponin ginseng, wild ginseng, this component has anti-cancer effect and is also used in clinical experiments.
이 황칠나무는 혈액순환을 원활히 하고 피 속의 콜레스테롤 수치를 정상적으로 해주는 효과가 있어 고혈압 환자들에게 도움이 된다. 또 혈당 수치를 적정수치로 만들어주기 때문에 당뇨환자들에게도 좋고, 손발 저림, 편두통, 수족냉증 같은 혈액순환 관련 질환에도 도움이 되며, 중풍이나 뇌출혈 예방 효과도 있다고 합니다.This hwangchil tree helps blood circulation and normalizes cholesterol levels in the blood, which helps patients with hypertension. It is also good for diabetics because it makes blood sugar levels appropriate, and it is also helpful for blood circulation-related diseases such as numbness of hands and feet, migraine, cold hands and hands, and prevents stroke and cerebral hemorrhage.
우리 치아에도 좋은 황칠나무는 치주세포 및 치아 재생에 도움이 되어 치아 관련 질환으로 고민을 하시는 분들에게도 도움이 된다. 바로 뼈 조직이 잘 재생될 수 있도록 효능이 있기 때문이다. 따라서 골다공증 예방에 도움이 되며 류머티스성 관절염에도 도움이 된다.Hwangchil wood is also good for our teeth is helpful for periodontal cells and tooth regeneration is also helpful for those concerned with tooth-related diseases. This is because bone tissue is effective in regenerating well. This helps prevent osteoporosis and also helps with rheumatoid arthritis.
조각자나무는, 실거리나무과(―科 Caesalpiniacea)에 속하는 낙엽교목으로, 키는 20m까지 자라고, 가지의 많은 큰 가시들은 자라면서 없어진다. Engraver is a deciduous tree belonging to the family Caesalpiniacea, growing up to 20m in height, and many large thorns of branches disappear as they grow.
이러한 조각자나무는 한방에서 가을에 가시와 열매를 따서 말려 약으로 쓰는데, 가시를 말린 조각자(早角刺)는 풍을 낫게 하고 살충효과가 있다. These carved trees are used in medicine to dry thorns and fruits in the fall in one room, and dried sculpted carcasses (早 角 刺) improve the wind and have an insecticidal effect.
영지버섯은 민주름 버섯목 불로초과에 속하는 버섯이다. 맛은 달고 쓰며 성질은 평하며 심, 비, 폐, 간경에 작용한다. 맛은 다섯 가지 맛이 나며 강장, 진정, 양신익정, 자보, 견근골한다고 하고, 항종양 억제율이 70~80 퍼센트 정도라 한다. Ganoderma lucidum is a mushroom belonging to the Democratic Fungi Buloba. The taste is sweet and bitter, the property is flat and acts on the heart, rain, lungs, and cirrhosis. It has five flavors, and is said to be tonic, soothing, Shin-Ikjeong, Szabo, and shoulder bones.
이러한 영지버섯은, 혈압조절, 혈장 및 간 콜레스테롤억제, 혈당 강하, 면역 증강, 보체계 및 망막계 활성, 노화억제, 생리활성, 세포활성, 항염, 항균, 항알레르기, 항히스타민, 항남성 호르몬, 해독, 정혈, 보간, 이뇨 작용[이뇨작용은 아주 강하다]을 한다. 최근에 에이즈 바이러스 억제작용을 한다는 것이 밝혀졌다고 한다.These ganoderma lucidum mushrooms, blood pressure control, plasma and liver cholesterol suppression, hypoglycemia, immune enhancement, complement system and retinal system activity, anti-aging, physiological activity, cellular activity, anti-inflammatory, antibacterial, anti-allergic, antihistamine, anti-male hormone, detoxification, Blood, interpolation, diuretic [diuretic action is very strong]. Recently, it has been found that it acts to suppress the AIDS virus.
주로 허로, 고혈압, 저혈압, 동맥경화, 신부전증, 뇌졸중, 건망증, 불면증, 위궤양, 급 만성간염, 신경쇠약, 관절염, 심장 및 위장 허약, 소화불량, 변비, 하리, 복통, 발열, 알레르기증, 빈혈, 심계항진, 도한, 신우신염, 폐결핵, 만성기관지염, 천식, 폐렴, 감기, 눈병, 비염, 중독, 탈모증, 성인병 등에 널리 작용한다. 현재 양모제의 원료로 이용된다. Mainly: hypertension, hypertension, hypotension, arteriosclerosis, kidney failure, stroke, forgetfulness, insomnia, gastric ulcer, sudden chronic hepatitis, nervous breakdown, arthritis, heart and gastrointestinal weakness, indigestion, constipation, Hari, abdominal pain, fever, allergy, anemia, Heart palpitations, Hanhan, pyelonephritis, pulmonary tuberculosis, chronic bronchitis, asthma, pneumonia, cold, eye disease, rhinitis, poisoning, alopecia, adult diseases, etc. It is currently used as a raw material for wool.
"살아서 천년 죽어서 천년"이라는 주목나무는, 그 껍질에서 추출한 파클리탁셀이라는 성분으로 미국 BMS사가 "택솔(taxol)"이라는 항암제를 만들어 효과가 뛰어나다는 사실이 밝혀지면서 기적의 항암제라 불리고 있다. The yew tree, "Alive and a Thousand Years," is called a miracle anticancer drug, as it was discovered that the US BMS made an effective anticancer drug called "taxol" with the ingredient called paclitaxel extracted from its bark.
"택솔"은 암세포에 영양분을 공급하는 혈관을 막는 것으로 다른 치료제와 함께 사용해 말기암 환자를 완치했다는 보고가 있을 정도로 효과가 있으나 부작용도 만만치 않다고 한다. 주목 나무의 잎에는 플라보노이드, 알칼로이드, 쿠마린이 들어있고 6월에 채취한 잎에는 택솔이 0.22%가 들어 있다고 합니다. "Taxol" works by blocking blood vessels that supply nutrients to cancer cells, which is effective enough to cure terminal cancer patients when used in combination with other treatments. The leaves of the yew tree contain flavonoids, alkaloids, and coumarin, and the leaves collected in June contain 0.22% taxol.
상기 주목나무열매는, 플라보노이드, 알칼로이드, 쿠마린이 들어 있어 여러 종류의 기침, 신경통, 동통성 질병에 효능이 있다고 한다. 또한 혈압을 낮추는 작용을 하며 통경, 이뇨, 당뇨병약으로 사용된다. The yew tree fruit, flavonoids, alkaloids, coumarin contains is said to be effective in various types of cough, neuralgia, pain. It also acts to lower blood pressure and is used for pain, diuresis and diabetes.
이상에서와 같이, 본 발명의 상세한 설명에서 구체적인 실시예에 관해 설명하였으나, 본 발명의 기술이 당업자에 의하여 용이하게 변형 실시될 가능성이 자명하며, 이러한 변형된 실시예들은 본 발명의 특허청구범위에 기재된 기술사상에 포함된다할 것이다.As described above, specific embodiments have been described in the detailed description of the present invention, but it is obvious that the technology of the present invention can be easily modified by those skilled in the art, and such modified embodiments are defined in the claims of the present invention. It will be included in the technical spirit described.
Claims (1)
엄나무 추출물 12~17 중량%와;
무환자나무 추출물 12~17 중량%와;
황칠나무 추출물 11~16 중량%와;
조각자나무 추출물 18~23 중량%와;
영지버섯 추출물 0.3~0.7중량% 및;
주목나무열매 추출물 0.3~0.7 중량%로 이루어진 것을 특징으로 하는 비파나무 추출물을 포함하는 조성물.
32-37 wt% of loquat extract;
12-17% by weight of the oak extract;
12-17% by weight of the extract from the tree;
Hwangchil-tree extract with 11 to 16% by weight;
18-23% by weight of the bark extract;
Ganoderma lucidum mushroom extract 0.3-0.7% by weight and;
Yew tree fruit extract composition comprising a loquat extract, characterized in that consisting of 0.3 ~ 0.7% by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180014672A KR20190094951A (en) | 2018-02-06 | 2018-02-06 | Compositions including eriobotrya japonica extracts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180014672A KR20190094951A (en) | 2018-02-06 | 2018-02-06 | Compositions including eriobotrya japonica extracts |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20190094951A true KR20190094951A (en) | 2019-08-14 |
Family
ID=67622339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180014672A KR20190094951A (en) | 2018-02-06 | 2018-02-06 | Compositions including eriobotrya japonica extracts |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20190094951A (en) |
-
2018
- 2018-02-06 KR KR1020180014672A patent/KR20190094951A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101868050B1 (en) | Fermentation method using medicinal flower and skin external composition containing fermented extract by the method | |
KR101805004B1 (en) | Fermentation method using medicinal leaf and skin external composition containing fermented extract by the method | |
KR100712658B1 (en) | Herbal composition for treating cancer | |
KR101162313B1 (en) | Farm work with natural herb medicines and red ginseng saponin | |
KR20150040392A (en) | undiluted stevia liquid and the berages, and its manufacturing method | |
CN106942133A (en) | A kind of cultural method of cockfighting | |
KR101148006B1 (en) | Manufacturing Process of Ginseng Chicken Broth Including Trepang and Ginseng Chicken Broth Manufactured thereby | |
KR100989944B1 (en) | A mixed herb medicine extracts having antioxidant whitening activity | |
KR101024429B1 (en) | Composition for feed for poultry comprising oriental herb | |
CN106701410A (en) | Healthcare wine capable of strengthening stomach and tonifying qi and production method thereof | |
KR100682046B1 (en) | Herbal extract for treating lupuse | |
KR101028073B1 (en) | Natural herb medicine composition improving blood circulation and immune activity of human body and its process of production | |
KR101479228B1 (en) | chicken soup | |
KR101145498B1 (en) | Method for manufacturing bodywash and bodywash composition thereof containing natural oriental plant extracts | |
CN107494635A (en) | For preventing and treating cucumber disease and improving the plant extracts of cucumber nutrient composition content | |
CN107416919A (en) | Efficiently remove the composition of Polychlorinated biphenyls in water body | |
KR20190094951A (en) | Compositions including eriobotrya japonica extracts | |
KR20110091959A (en) | Anhydrous lactobacillus fermentation health function food composition with cancer curing improvements and its preparation method | |
KR20160111646A (en) | Method for producing of new material for Improving GOUT, Reducing URIC Acid | |
KR20200101169A (en) | Method of making fermented food using pine cone | |
KR20030005129A (en) | Health food with the theme of hamcho and ogapi | |
KR20030005127A (en) | Healthy foods on earth and alder | |
CN105055597B (en) | The Chinese materia medica preparation and its production method for treating peacock enterogastritis | |
Shah | Ethnobiological Lores from the Kumaon culture of India | |
KR102487450B1 (en) | Chewing gum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |